Sfoglia per Autore
Generation of Bioengineered Biliary Tissue Using Primary in Vitro Propagated Extra-Hepatic Cholangiocytes and Biodegradable Scaffolds
2016-01-01 Sampaziotis, F.; de Brito, M.C.; Sawiak, S.; Godfrey, E.; Ortmann, D.; Bertero, A.; Upponi, S.; Pawlowski, M.; Georgakopoulos, N.; Bargehr, J.; Hannan, N.; Gelson, W.; Alexander, G.; Saeb-Parsy, K.; Vallier, L.
Optimized inducible shRNA and CRISPR/Cas9 platforms for in vitro studies of human development using hPSCs
2016-01-01 Bertero A.; Pawlowski M.; Ortmann D.; Snijders K.; Yiangou L.; De Brito M.C.; Brown S.; Bernard W.G.; Cooper J.D.; Giacomelli E.; Gambardella L.; Hannan N.R.F.; Iyer D.; Sampaziotis F.; Serrano F.; Zonneveld M.C.F.; Sinha S.; Kotter M.; Vallier L.
Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation
2015-01-01 Sampaziotis F.; De Brito M.C.; Madrigal P.; Bertero A.; Saeb-Parsy K.; Soares F.A.C.; Schrumpf E.; Melum E.; Karlsen T.H.; Bradley J.A.; Gelson W.T.H.; Davies S.; Baker A.; Kaser A.; Alexander G.J.; Hannan N.R.F.; Vallier L.
Activin/Nodal signaling and NANOG orchestrate human embryonic stem cell fate decisions by controlling the H3K4me3 chromatin mark
2015-01-01 Bertero A.; Madrigal P.; Galli A.; Hubner N.C.; Moreno I.; Burks D.; Brown S.; Pedersen R.A.; Gaffney D.; Mendjan S.; Pauklin S.; Vallier L.
Fucci2a mouse upgrades live cell cycle imaging
2015-01-01 Bertero A.; Vallier L.
IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload.
2011-01-01 Sbroggiò M; Carnevale D; Bertero A; Cifelli G; De Blasio E; Mascio G; Hirsch E; Bahou WF; Turco E; Silengo L; Brancaccio M; Lembo G; Tarone G
ERK1/2 activation in heart is controlled by melusin, focal adhesion kinase and the scaffold protein IQGAP1.
2011-01-01 Sbroggiò M; Bertero A; Velasco S; Fusella F; De Blasio E; Bahou WF; Silengo L; Turco E; Brancaccio M; Tarone G.
Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities
2011-01-01 Bulliard Y.; Narvaiza I.; Bertero A.; Peddi S.; Rohrig U.F.; Ortiz M.; Zoete V.; Castro-Diaz N.; Turelli P.; Telenti A.; Michielin O.; Weitzman M.D.; Trono D.
Morgana and Melusin: Two fairies chaperoning signal transduction.
2011-01-01 Ferretti R; Sbroggiò M; Di Savino A; Fusella F; Bertero A; Michowski W; Tarone G; Brancaccio M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Generation of Bioengineered Biliary Tissue Using Primary in Vitro Propagated Extra-Hepatic Cholangiocytes and Biodegradable Scaffolds | 2016 | Sampaziotis, F.; de Brito, M.C.; Sawiak, S.; Godfrey, E.; Ortmann, D.; Bertero, A.; Upponi, S.; Pawlowski, M.; Georgakopoulos, N.; Bargehr, J.; Hannan, N.; Gelson, W.; Alexander, G.; Saeb-Parsy, K.; Vallier, L. | |
| Optimized inducible shRNA and CRISPR/Cas9 platforms for in vitro studies of human development using hPSCs | 2016 | Bertero A.; Pawlowski M.; Ortmann D.; Snijders K.; Yiangou L.; De Brito M.C.; Brown S.; Bernard W.G.; Cooper J.D.; Giacomelli E.; Gambardella L.; Hannan N.R.F.; Iyer D.; Sampaziotis F.; Serrano F.; Zonneveld M.C.F.; Sinha S.; Kotter M.; Vallier L. | |
| Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation | 2015 | Sampaziotis F.; De Brito M.C.; Madrigal P.; Bertero A.; Saeb-Parsy K.; Soares F.A.C.; Schrumpf E.; Melum E.; Karlsen T.H.; Bradley J.A.; Gelson W.T.H.; Davies S.; Baker A.; Kaser A.; Alexander G.J.; Hannan N.R.F.; Vallier L. | |
| Activin/Nodal signaling and NANOG orchestrate human embryonic stem cell fate decisions by controlling the H3K4me3 chromatin mark | 2015 | Bertero A.; Madrigal P.; Galli A.; Hubner N.C.; Moreno I.; Burks D.; Brown S.; Pedersen R.A.; Gaffney D.; Mendjan S.; Pauklin S.; Vallier L. | |
| Fucci2a mouse upgrades live cell cycle imaging | 2015 | Bertero A.; Vallier L. | |
| IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload. | 2011 | Sbroggiò M; Carnevale D; Bertero A; Cifelli G; De Blasio E; Mascio G; Hirsch E; Bahou WF; Turco E; Silengo L; Brancaccio M; Lembo G; Tarone G | |
| ERK1/2 activation in heart is controlled by melusin, focal adhesion kinase and the scaffold protein IQGAP1. | 2011 | Sbroggiò M; Bertero A; Velasco S; Fusella F; De Blasio E; Bahou WF; Silengo L; Turco E; Brancaccio M; Tarone G. | |
| Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities | 2011 | Bulliard Y.; Narvaiza I.; Bertero A.; Peddi S.; Rohrig U.F.; Ortiz M.; Zoete V.; Castro-Diaz N.; Turelli P.; Telenti A.; Michielin O.; Weitzman M.D.; Trono D. | |
| Morgana and Melusin: Two fairies chaperoning signal transduction. | 2011 | Ferretti R; Sbroggiò M; Di Savino A; Fusella F; Bertero A; Michowski W; Tarone G; Brancaccio M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile